Bröstcancer – Team Afsar Rahbar

Studies of the importance of Cytomegalovirus infection in breast cancer

Recently, Human cytomegalovirus (HCMV) infection has been found in breast cancer. Our research group has recently detected HCMV in most neoplastic cells in sentinel lymph nodes and brain metastases (BMs) of breast cancer. The exact mechanism by which BMs develop is unknown. Several risk factors are associated with BMs. These include human epidermal growth factor receptor 2 positive breast cancer, triple-negative breast cancer and COX-2 expression, as well as enhanced expression of integrin αvβ3, CXCR4/SDF-1 and CD44. COX-2 expression is thought to mediate impaired blood-brain barrier functions, while CXCR4/SDF-1, CD44, and integrin αvβ3 are thought to mediate increased metastatic potential to the brain and promote angiogenesis, which may contribute to the development of BM. HCMV infection induces CD40 expression on the surface of the infected cells that interact with CD40L and results in VEGF production. Moreover, increased expression of integrin αvβ3, CXCR4/SDF-1, and CD44 may promote angiogenesis and initiate metastasis formation. High expression of HCMV-US27, another putative chemokine receptor, has been associated with enhanced expression of CXCR4 and induces cellular migration. In addition, HCMV infection increase expression of CD44, which increases cell–cell interactions, cell adhesion, and migration of infected
cells. The prevalence of HCMV proteins and nucleic acids is very high in primary and metastatic tumors and may drive the development of metastasis; therefore, this virus may represent a potential therapeutic target in metastatic cancer. The long term goal of my study is to further understand the oncomodulatory role of HCMV in breast cancer and metastasis formation.

Supervised PhD candidates:
Soley Omardottir, MD, PhD
Chato Taher, MD, PhD
Mensur Dzabic, MD, PhD

Ongoing supervision of a PhD candidates:
Olesja Fornara, MD,
Abdul-Aleem Mohammad, MSc,
Atosa Estekizadeh, MSc
Xinling Xu, MD,
Jiri Bartek, MD

Supervision of PhD holder researcher/post docs:
Helena Costa, Post doc
Melinda Bernard, MD, post doc

CMM Research Groups